Company

Immusoft

Biotechnology Research Seattle, Washington, United States 22 employees

Employees: 22
Contacts: 3
Emails: 3
Phones: 3

immusoft.com LinkedIn

Immusoft Overview

Headquarters: Seattle, Washington, United States
Website: immusoft.com
Industry: Biotechnology Research
Employees: 22
Founded: 2009
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

rare diseases B cells cell therapy

About Immusoft

Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using sustained delivery of therapeutic proteins from a patient’s own cells. The company is developing a technology platform called Immune System Programming (ISP™), which modifies a patient’s B cells and instructs them to produce gene-encoded medicines. The B cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients and provide therapeutic benefit for many years. The company is based in Seattle, WA.

Immusoft Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

Immusoft Org Chart

Sample employees and titles

Name	Title	Location	Contact
Eric Garcia			View
David Romenesko	Legacy Wealth Advisors (Retired)	Midland, Michigan, United States	Email Phone
Matthew Scholz	Founder and Chief Executive Officer	Seattle, Washington, United States	Email Phone
Julia Moore	Co-founder and Managing Partner	San Francisco, California, United States	Email Phone